Real life dose emission characterization using COPD patient inhalation profiles when they inhaled using a fixed dose combination (FDC) of the medium strength Symbicort ® Turbuhaler ®-Reference-Cited by-同舟云学术

Real life dose emission characterization using COPD patient inhalation profiles when they inhaled using a fixed dose combination (FDC) of the medium strength Symbicort ® Turbuhaler ®

Published:2017-04 Issue:1-2 Volume:522 Page:137-146
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Bagherisadeghi Golshan,Larhrib El Hassane,Chrystyn Henry

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference34 articles.

1. High performance liquid chromatography assay method for simultaneous quantitation of formoterol and budesonide in Symbicort® Turbuhaler®;Assi;J. Pharm. Biomed. Anal.,2006

2. The inhalation characteristics of patients when they use different dry powder inhalers;Azouz;J. Aerosol Med. Pulm. Drug Deliv.,2015

3. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study;Azouz;BMC Pulm. Med.,2015

4. Fine particle mass from the Diskus inhaler and Turbuhaler® inhaler in children with asthma;Bisgaard;Eur. Respir. J.,1998

5. Lung deposition of budesonide inhaled via Turbuhaler®: a comparison with terbutaline sulphate in normal subjects;Borgström;Eur. Respir. J.,1994

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-Time Particle Emission Monitoring for the Non-Invasive Prediction of Lung Deposition via a Dry Powder Inhaler;AAPS PharmSciTech;2024-05-10

2. The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions;International Journal of Pharmaceutics: X;2023-12

3. A varying-swirl design concept for dry powder inhalers;Journal of Aerosol Science;2023-06

4. High inhaler resistance does not limit successful inspiratory maneuver among patients with asthma or COPD;Expert Opinion on Drug Delivery;2023-02-26

5. A review of upper airway physiology relevant to the delivery and deposition of inhalation aerosols;Advanced Drug Delivery Reviews;2022-12